Jun 5, 2013 1:33 PM by NBC News
Once the top-selling diabetes drug in the world, sales of Avandia plummeted in 2007 after an analysis of studies suggested it increased the risk for heart attack.
Now, the FDA is taking another look at the drug, after new research finds it may not be as dangerous as doctors once thought.
Experts at Duke Clinical Research Institute re-analyzed the study that assessed the heart risks for patients taking the drug Avandia.
They found the drug is as safe as older diabetes drugs and say they could not find any concerning heart risks.
A group of FDA advisors will vote on whether safety restrictions placed on Avandia in 2010 should be removed, adjusted, or if the drug should be removed from the market.
There are only 3,000 active prescriptions for Avandia in the U.S. right now, compared to nearly 3 million in 2009.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at firstname.lastname@example.org, and include the name of the story and information on the comment.
Thank you! KSBY.com